Arteriosclerosis, Vol 9, 326-334, Copyright © 1989 by American Heart Association

ARTICLES

Detection and characterization of the heterozygote state for lipoprotein lipase deficiency

SP Babirak, PH Iverius, WY Fujimoto and JD Brunzell
Division of Metabolism, University of Washington, Seattle.

Because there are no characteristic clinical or biochemical manifestations, the heterozygote state for lipoprotein lipase (LPL) deficiency has been difficult to detect. Measurements of postheparin plasma LPL activity and of LPL mass were performed in six families of probands with LPL deficiency to characterize the heterozygote state. LPL mass was measured in a sandwich enzyme-linked immunosorbent assay (ELISA) using a monoclonal antibody (5D2) that had been produced against bovine milk LPL. Thirteen obligate heterozygotes from these families had reduced LPL activity and mass below the 95th percent confidence limits of 34 normal controls, while one obligate heterozygote had LPL activity and mass between the 90th and 95th percent confidence limits. Potential heterozygotes in these families were identified as normal (n = 8) or heterozygotes (n = 6) by comparison to the 95th percent confidence limits of the controls. Some relatives in four of the six families exhibited mild hyperlipidemia, similar to the pattern seen in familial combined hyperlipidemia (FCHL). The hyperlipidemia segregated with the heterozygote state for LPL deficiency in these families (p less than 0.03). High density lipoprotein (HDL) cholesterol was significantly reduced in the heterozygotes for LPL deficiency (p less than 0.01). The measurement of LPL activity and mass allows identification of the heterozygote state for LPL deficiency, which is characterized by variable expressions of hyperlipidemia and reduced HDL cholesterol. These results suggest that the heterozygote state for LPL deficiency may form one subset of FCHL.

This article has been cited by other articles:

				G. P. Jarvik, J. D. Brunzell, and A. G. Motulsky Frequent Detection of Familial Hypercholesterolemia Mutations in Familial Combined Hyperlipidemia J. Am. Coll. Cardiol., November 4, 2008; 52(19): 1554 - 1556. [Full Text] [PDF]

				S. Imamura, J. Kobayashi, K. Nakajima, S. Sakasegawa, A. Nohara, T. Noguchi, M. A. Kawashiri, A. Inazu, S. S. Deeb, H. Mabuchi, et al. A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma J. Lipid Res., July 1, 2008; 49(7): 1431 - 1437. [Abstract] [Full Text] [PDF]

				J. Wang, H. Cao, M. R. Ban, B. A. Kennedy, S. Zhu, S. Anand, S. Yusuf, R. L. Pollex, and R. A. Hegele Resequencing Genomic DNA of Patients With Severe Hypertriglyceridemia (MIM 144650) Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2450 - 2455. [Abstract] [Full Text] [PDF]

				J. Rip, M. C. Nierman, C. J. Ross, J. W. Jukema, M. R. Hayden, J. J.P. Kastelein, E. S.G. Stroes, and J. A. Kuivenhoven Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1236 - 1245. [Abstract] [Full Text] [PDF]

				V. Charlton-Menys and P. N. Durrington Apolipoprotein A5 and Hypertriglyceridemia Clin. Chem., February 1, 2005; 51(2): 295 - 297. [Full Text] [PDF]

				T. L. McIlhargey, Y. Yang, H. Wong, and J. S. Hill Identification of a Lipoprotein Lipase Cofactor-binding Site by Chemical Cross-linking and Transfer of Apolipoprotein C-II-responsive Lipolysis from Lipoprotein Lipase to Hepatic Lipase J. Biol. Chem., June 13, 2003; 278(25): 23027 - 23035. [Abstract] [Full Text] [PDF]

				J. Peterson, A. F. Ayyobi, Y. Ma, H. Henderson, M. Reina, S. S. Deeb, S. Santamarina-Fojo, M. R. Hayden, and J. D. Brunzell Structural and functional consequences of missense mutations in exon 5 of the lipoprotein lipase gene J. Lipid Res., March 1, 2002; 43(3): 398 - 406. [Abstract] [Full Text] [PDF]

				A. Zambon, S. S. Deeb, A. Bensadoun, K. E. Foster, and J. D. Brunzell In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity J. Lipid Res., December 1, 2000; 41(12): 2094 - 2099. [Abstract] [Full Text]

				B. E. Aouizerat, H. Allayee, R. M. Cantor, G. M. Dallinga-Thie, C. D. Lanning, T. W. A. de Bruin, A. J. Lusis, and J. I. Rotter Linkage of a Candidate Gene Locus to Familial Combined Hyperlipidemia : Lecithin:Cholesterol Acyltransferase on 16q Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2730 - 2736. [Abstract] [Full Text] [PDF]

				A. Zambon, J. E. Hokanson, B. G. Brown, and J. D. Brunzell Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression : Hepatic Lipase–Mediated Changes in LDL Density Circulation, April 20, 1999; 99(15): 1959 - 1964. [Abstract] [Full Text] [PDF]

				S.-F. Chang, B. Reich, J. D. Brunzell, and H. Will Detailed characterization of the binding site of the lipoprotein lipase-specific monoclonal antibody 5D2 J. Lipid Res., December 1, 1998; 39(12): 2350 - 2359. [Abstract] [Full Text]

				A. Zambon, S. S. Deeb, J. E. Hokanson, B. G. Brown, and J. D. Brunzell Common Variants in the Promoter of the Hepatic Lipase Gene Are Associated With Lower Levels of Hepatic Lipase Activity, Buoyant LDL, and Higher HDL2 Cholesterol Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1723 - 1729. [Abstract] [Full Text] [PDF]

				E. Tahvanainen, P. Pajukanta, K. Porkka, S. Nieminen, L. Ikavalko, I. Nuotio, M.-R. Taskinen, L. Peltonen, and C. Ehnholm Haplotypes of the ApoA-I/C-III/A-IV Gene Cluster and Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1810 - 1817. [Abstract] [Full Text] [PDF]

				E. M. Wijsman, J. D. Brunzell, G. P. Jarvik, M. A. Austin, A. G. Motulsky, and S. S. Deeb Evidence Against Linkage of Familial Combined Hyperlipidemia to the Apolipoprotein AI-CIII-AIV Gene Complex Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 215 - 226. [Abstract] [Full Text] [PDF]

				J. Ribalta, A. E. LaVille, J. Girona, J. C. Vallve, and L. Masana Low plasma vitamin A concentrations in familial combined hyperlipidemia Clin. Chem., December 1, 1997; 43(12): 2379 - 2383. [Abstract] [Full Text] [PDF]

				S. Reynisdottir, B. Angelin, D. Langin, H. Lithell, M. Eriksson, C. Holm, and P. Arner Adipose Tissue Lipoprotein Lipase and Hormone-Sensitive Lipase : Contrasting Findings in Familial Combined Hyperlipidemia and Insulin Resistance Syndrome Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2287 - 2292. [Abstract] [Full Text]

				B. G. Nordestgaard, S. Abildgaard, H. H. Wittrup, R. Steffensen, G. Jensen, and A. Tybjærg-Hansen Heterozygous Lipoprotein Lipase Deficiency : Frequency in the General Population, Effect on Plasma Lipid Levels, and Risk of Ischemic Heart Disease Circulation, September 16, 1997; 96(6): 1737 - 1744. [Abstract] [Full Text]

				S. Levak-Frank, P. H. Weinstock, T. Hayek, R. Verdery, W. Hofmann, R. Ramakrishnan, W. Sattler, J. L. Breslow, and R. Zechner Induced Mutant Mice Expressing Lipoprotein Lipase Exclusively in Muscle Have Subnormal Triglycerides yet Reduced High Density Lipoprotein Cholesterol Levels in Plasma J. Biol. Chem., July 4, 1997; 272(27): 17182 - 17190. [Abstract] [Full Text] [PDF]

				M. Rouis, K. A. Dugi, L. Previato, A. P. Patterson, J. D. Brunzell, H. B. Brewer, and S. Santamarina-Fojo Therapeutic Response to Medium-Chain Triglycerides and {omega}-3 Fatty Acids in a Patient With the Familial Chylomicronemia Syndrome Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1400 - 1406. [Abstract] [Full Text]

				B. E. Groenemeijer, M. D. Hallman, P. W.A. Reymer, E. Gagne, J. A. Kuivenhoven, T. Bruin, H. Jansen, K. I. Lie, A. V.G. Bruschke, E. Boerwinkle, et al. Genetic Variant Showing a Positive Interaction With ß-Blocking Agents With a Beneficial Influence on Lipoprotein Lipase Activity, HDL Cholesterol, and Triglyceride Levels in Coronary Artery Disease Patients: The Ser447-Stop Substitution in the Lipoprotein Lipase Gene Circulation, June 17, 1997; 95(12): 2628 - 2635. [Abstract] [Full Text]

				P. Pajukanta, K. V.K. Porkka, M. Antikainen, M.-R. Taskinen, M. Perola, S. Murtomaki-Repo, S. Ehnholm, I. Nuotio, L. Suurinkeroinen, A.-T. Lahdenkari, et al. No Evidence of Linkage Between Familial Combined Hyperlipidemia and Genes Encoding Lipolytic Enzymes in Finnish Families Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 841 - 850. [Abstract] [Full Text]

				S. K. Parsons, S. X. Skapek, E. J. Neufeld, C. Kuhlman, M. L. Young, M. Donnelly, J. D. Brunzell, J. D. Otvos, S. E. Sallan, and N. Rifai Asparaginase-Associated Lipid Abnormalities in Children With Acute Lymphoblastic Leukemia Blood, March 15, 1997; 89(6): 1886 - 1895. [Abstract] [Full Text] [PDF]

				K. A. Dugi, I. M. Feuerstein, S. Hill, J. Shih, S. Santamarina-Fojo, H. B. B. Jr, and J. M. Hoeg Lipoprotein Lipase Correlates Positively and Hepatic Lipase Inversely With Calcific Atherosclerosis in Homozygous Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, February 1, 1997; 17(2): 354 - 364. [Abstract] [Full Text]

				D. L. Sprecher, B. V. Harris, E. A. Stein, P. S. Bellet, L. M. Keilson, and L. A. Simbartl Higher Triglycerides, Lower High-Density Lipoprotein Cholesterol, and Higher Systolic Blood Pressure in Lipoprotein Lipase–Deficient Heterozygotes: A Preliminary Report Circulation, December 15, 1996; 94(12): 3239 - 3245. [Abstract] [Full Text]

				P. Benlian, J. L. De Gennes, L. Foubert, H. Zhang, S. E. Gagne, and M. Hayden Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase Gene N. Engl. J. Med., September 19, 1996; 335(12): 848 - 854. [Abstract] [Full Text] [PDF]

				H. Zhang, P. W. A. Reymer, M.-S. Liu, I. J. Forsythe, B. E. Groenemeyer, J. Frohlich, J. D. Brunzell, J. J. P. Kastelein, M. R. Hayden, and Y. Ma Patients With ApoE3 Deficiency (E2/2, E3/2, and E4/2) Who Manifest With Hyperlipidemia Have Increased Frequency of an Asn 291->Ser Mutation in the Human LPL Gene Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1695 - 1703. [Abstract] [Full Text]

				T. Coleman, R. L. Seip, J. M. Gimble, D. Lee, N. Maeda, and C. F. Semenkovich COOH-terminal Disruption of Lipoprotein Lipase in Mice Is Lethal in Homozygotes, but Heterozygotes Have Elevated Triglycerides and Impaired Enzyme Activity J. Biol. Chem., May 26, 1995; 270(21): 12518 - 12525. [Abstract] [Full Text] [PDF]

				F. Mailly, Y. Tugrul, P. W. A. Reymer, T. Bruin, M. Seed, B. F. Groenemeyer, A. Asplund-Carlson, D. Vallance, A. F. Winder, G. J. Miller, et al. A Common Variant in the Gene for Lipoprotein Lipase (Asp9->Asn) : Functional Implications and Prevalence in Normal and Hyperlipidemic Subjects Arterioscler Thromb Vasc Biol, April 1, 1995; 15(4): 468 - 478. [Abstract] [Full Text]

				M. Dammerman and J. L. Breslow Genetic Basis of Lipoprotein Disorders Circulation, January 15, 1995; 91(2): 505 - 512. [Full Text]

				A. Sarria, L. A. Moreno, M. Mur, A. Lazaro, and M. Bueno Usefulness of Serum Apolipoprotein B Levels for Screening Children With Primary Dyslipoproteinemias Arch Pediatr Adolesc Med, October 1, 1992; 146(10): 1230 - 1231. [Abstract] [PDF]

				S. L. Sanderson, P.-H. Iverius, and D. E. Wilson Successful Hyperlipemic Pregnancy JAMA, April 10, 1991; 265(14): 1858 - 1860. [Abstract] [PDF]

				S. Santamarina-Fojo and H. B. Brewer Jr The Familial Hyperchylomicronemia Syndrome: New Insights Into Underlying Genetic Defects JAMA, February 20, 1991; 265(7): 904 - 908. [Abstract] [PDF]